Join
Live feed
·
SECFilingvia Quantisnow
Titan Pharmaceuticals Inc. logo

Titan Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Changes in Registrant's Certifying Accountant, Other Events, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
TTNP· Titan Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TTNP (Titan Pharmaceuticals Inc.) and more on Quantisnow.